The making of DNA

Enabling the genetic medicine revolution with our unique dbDNA™ technology.

How we make DNA
Platform Technology

Powering the genetic medicine revolution

Our novel, synthetic DNA vector, “doggybone” or dbDNA™, and its enzymatic production, enable us to make DNA at the speed, scale and purity necessary to support the rapid growth of genetic medicines.

DNA made using enzymes

We are disrupting the decades-old technology of DNA production, moving away from restrictive biological approaches to instead use a synthetic

Our platform technology
Rapid icon

Enzymatic manufacturing enables multi-gram GMP DNA production in weeks rather than months

Scalable icon

Manufactured using benchtop equipment with a significantly smaller footprint than fermentation-based production

Mobile icon

dbDNA™ technology is highly portable and amenable to technology transfer

Optimal vector icon
Optimal vector

dbDNA™ can encode long, complex, unstable sequences, eliminates bacterial sequences, and has a strong expression profile

Addressing a broad market

Our versatile dbDNA™ technology is being applied across the genetic medicine industry.

Our Services

What can we do for you?

We offer a range of services to support development and commercialisation of the next generation of DNA products.

Pre-clinical services
Pre-clinical services
  • Catalogue products
  • Molecular biology
  • Custom research grade
  • Toxicology materials
Find out more
GMP Supply
GMP supply
  • GMP dbDNA™ (critical starting materials)
  • GMP dbDNA™ (drug substance)
  • Commercial supply / on-site supply
Find out more
Development Services
Development Services
  • Analytical development
  • Scale up development
  • Formulation
  • Stability
Find out more
Regulatory Support
Regulatory support
  • Regulatory support
Find out more
Our facilities

Headquartered in Hampton

Take a tour of our stunning buildings and state-of-the-art dbDNA™ manufacturing facilities.

View our facilities
Our programs and partners

Work with us to develop the next generation of DNA products

We are working in collaboration with esteemed partners, to leverage dbDNA™ in areas where it may offer unique or improved therapies or devices.

Find out more

Knowledge Centre

Facilities banner
TOPRA – Navigating the regulatory challenges of plasmid DNA and synthetic DNA as starting materials for mRNA vaccines
Read Article
Drug Delivery Today – dbDNA™ an advanced platform for genetic medicines
Read Article
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Read Article
Doggybone DNA for human iPSC
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Read Article
DNA vaccines
DNA Vaccines: The Next Stage in the Vaccine Revolution?
Read more
Touchlight DNA synthesis platform
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Read more
Knowledge centre
Contact us

We'd like to hear from you

For more information on how our dbDNA™ technology could help advance your project, please contact us.

Get in touch